DAWN MCKENNA: Open Payments
NPI 1942751359 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 13 payments from 7 companies in 2025. Trend: 2023 $113 · 2024 $102 · 2025 $357
Food & beverage: $266Education: $91
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $113 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Alkermes, Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, Qelbree.
Industry payments across TX — which companies pay providers there.
